Gene · 28898
Papers2,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,763
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genotype-phenotype correlation in patients with deletional and nondeletional mutations of Hb H disease in Southwest of Iran. | Sci Rep | 2022 | 35319015 | PubTator, text mining | PubMed |
| Speeding Up Reachability Queries in Public Transport Networks Using Graph Partitioning. | Inf Syst Front | 2022 | 35310777 | PubTator, text mining | PubMed |
| Sex differences in GABAA receptor subunit transcript expression are mediated by genotype in subjects with alcohol-related cirrhosis of the liver. | Genes Brain Behav | 2022 | 35301805 | PubTator, text mining | PubMed |
| Annexins A1 and A2 are recruited to larger lysosomal injuries independently of ESCRTs to promote repair. | FEBS Lett | 2022 | 35274304 | PubTator, text mining | PubMed |
| How Does the Immune System Enter the Brain? | Front Immunol | 2022 | 35273596 | PubTator, text mining | PubMed |
| Selectivity of 1-O-Propargyl-d-Mannose Preparations. | Molecules | 2022 | 35268584 | PubTator, text mining | PubMed |
A Systematic Comparative Assessment of the Response of Ovarian Cancer Cells to the Chemotherapeutic Cisplatin in 3D Models of Various Structural and Biochemical Configurations-Does One Model Type Fit All? | Cancers (Basel) | 2022 | 35267582 | PubTator, text mining | PubMed |
| The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity. | J Cell Biol | 2022 | 35266954 | PubTator, text mining | PubMed |
| The YΦ motif defines the structure-activity relationships of human 20S proteasome activators. | Nat Commun | 2022 | 35264557 | PubTator, text mining | PubMed |
| Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved? | Front Mol Biosci | 2022 | 35252355 | PubTator, text mining | PubMed |
| Interactions between 2'-fluoro-(carbamoylpyridinyl)deschloroepibatidine analogues and acetylcholine-binding protein inform on potent antagonist activity against nicotinic receptors. | Acta Crystallogr D Struct Biol | 2022 | 35234149 | PubTator, text mining | PubMed |
| α4-Integrin deficiency in human CD34+ cells engenders precocious erythroid differentiation but inhibits enucleation. | Exp Hematol | 2022 | 35227527 | PubTator, text mining | PubMed |
| Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits. | Front Genet | 2022 | 35222535 | PubTator, text mining | PubMed |
| A Comparison of Mother's Milk and the Neonatal Urine Metabolome: A Unique Fingerprinting for Different Nutritional Phenotypes. | Metabolites | 2022 | 35208187 | PubTator, text mining | PubMed |
| Selective Forms of Therapy in the Treatment of Inflammatory Bowel Diseases. | J Clin Med | 2022 | 35207271 | PubTator, text mining | PubMed |
| Ras Multimers on the Membrane: Many Ways for a Heart-to-Heart Conversation. | Genes (Basel) | 2022 | 35205266 | PubTator, text mining | PubMed |
| Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes. | J Extracell Vesicles | 2022 | 35188342 | PubTator, text mining | PubMed |
| Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome. | Sci Rep | 2022 | 35177655 | PubTator, text mining | PubMed |
| Integrin Signaling in the Central Nervous System in Animals and Human Brain Diseases. | Int J Mol Sci | 2022 | 35163359 | PubTator, text mining | PubMed |
| Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective. | Neurotoxicology | 2022 | 35150755 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28898/papers?page=15